“You're never really off time”: Healthcare providers' interpretations of optimal timing for HPV vaccination

• Many healthcare providers report a lack of concern for HPV vaccine completion by age 12.
• Providers reported concern about HPV vaccine initiation or completion beginning several years past the recommended target age.
• Providers described a gradient of on-time HPV vaccination ranging from age 12 to age 26.
• Providers refined their HPV vaccine recommendations based on perceptions of access to care and patient risk.
• Future interventions aimed at providers should emphasize messages on the importance of HPV vaccination by age 12.

Healthcare providers have a strong influence on human papillomavirus (HPV) vaccination decisions, yet they often fail to recommend the vaccine to the 11- and 12-year-olds who are targeted by practice guidelines. We sought to understand how providers interpret and value age-based guidelines.We conducted a secondary analysis of data from two qualitative studies of healthcare providers' HPV vaccination attitudes and practices. Participants were physicians, nurse practitioners, and physician assistants in Minnesota (n = 27) and in Washington (n = 17) interviewed in 2012 and 2014 respectively. Verbatim transcripts from each study were analyzed independently using content analysis, and collective findings were then jointly analyzed. The research team worked via consensus to derive codes and describe representative themes.A high proportion of providers reported either a lack of concern about HPV vaccine completion, or concern beginning several years past the recommended target age. Many providers perceived a gradient of HPV vaccination timeliness ranging from age 12 to 26. Instead of age-based recommendations, providers timed recommendations based on perceptions of access to care and patient risk. They often offered “gentle” recommendations and deferred vaccination discussions as a tool to building trust with families.Interventions aimed at helping providers deliver effective recommendations for timely HPV vaccination are needed. Our findings suggest that changing the norm of provider culture to one in which “catch-up” schedules are seen as a suboptimal way to achieve vaccine uptake may be an important goal.